HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tetrasomy 15q25.3 --> qter resulting from an analphoid supernumerary marker chromosome in a patient with multiple anomalies and bilateral Wilms tumors.

Abstract
We describe a girl who had been followed since birth for apparent Shprintzen-Goldberg syndrome (SGS), with macrosomia, long fingers and toes, and craniosynostosis, and presented at 4 years of age with bilateral Wilms tumors (also called nephroblastoma). Cytogenetic analysis of her peripheral blood revealed a de novo supernumerary marker chromosome. This stable marker chromosome is present in 19 of 20 lymphocytes analyzed, as well as in all 40 tumor cells (20 from each tumor) studied. Classical and molecular cytogenetic studies indicate that the marker is derived from an inverted duplication of chromosome 15q25.3 --> qter and contains a neocentromere. The presence of this marker chromosome in our patient results in tetrasomy 15q25.3 --> qter. The relationship between her genotype and phenotype are discussed in light of genes, including IGF1R and FES, mapped to the aneusomic segment.
AuthorsJ Hu, E McPherson, U Surti, S L Hasegawa, S Gunawardena, S M Gollin
JournalAmerican journal of medical genetics (Am J Med Genet) Vol. 113 Issue 1 Pg. 82-8 (Nov 15 2002) ISSN: 0148-7299 [Print] United States
PMID12400070 (Publication Type: Case Reports, Journal Article, Review)
CopyrightCopyright 2002 Wiley-Liss, Inc.
Chemical References
  • DNA
Topics
  • Abnormalities, Multiple (genetics)
  • Aneuploidy
  • Bone Diseases, Developmental (genetics)
  • Child, Preschool
  • Chromosome Mapping
  • Chromosomes, Human, Pair 15
  • DNA (blood, genetics, isolation & purification)
  • Female
  • Humans
  • Karyotyping
  • Kidney (pathology)
  • Kidney Neoplasms (genetics, pathology)
  • Lymphocytes (pathology)
  • Wilms Tumor (genetics, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: